FANJ
ADMA icon

Financial Architects (New Jersey)’s ADMA Biologics ADMA Stock Holding History

Financial Architects (New Jersey)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,500
Closed -$87K – 899
2019
Q3 		$87K Hold
19,500
– – 0.02% 352
2019
Q2 		$75K Buy
19,500
+1,000
+5% +$4.41K 0.01% 426
2019
Q1 		$70K Hold
18,500
– – 0.01% 535
2018
Q4 		$44K Buy
18,500
+3,500
+23% +$17.3K 0.01% 579
2018
Q3 		$93K Hold
15,000
– – 0.02% 484
2018
Q2 		$68K Buy
+15,000
New +$74.8K 0.01% 485

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $131M AUM 101.21% 1-Year Est. Return

Financial Architects (New Jersey)'s ADMA Position: Q4 2019 in Review

Financial Architects (New Jersey) sold out of ADMA Biologics (ADMA) in Q4 2019, closing a stake of 19,500 shares — an estimated $87K sold.

Financial Architects (New Jersey) first reported a position in ADMA in Q2 2018 and held it in 6 quarters. The position peaked at $93K in Q3 2018. 74 funds tracked by Wall St. Rank hold ADMA as of Q4 2019.

  • Financial Architects (New Jersey) reported no remaining ADMA Biologics position as of Q4 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 19,500 ADMA Biologics shares in Q4 2019, an estimated $87K.
  • Financial Architects (New Jersey) first reported a position in ADMA Biologics in Q2 2018 and held it in 6 quarters.
  • Financial Architects (New Jersey)'s ADMA Biologics position peaked at $93K in Q3 2018.
  • 74 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2019, filed 14 Feb 2020.